
Winter 2024
By Cyrena Musset
The Pancreatic Cancer Action Network recently awarded $400,000 in grant funding to Institute researchers Julien Dilly, MS, and William Freed-Pastor, MD, PhD, to better understand mechanisms of response and resistance to KRAS inhibition in pancreatic cancer and improve existing pre-clinical models for this intractable disease.
